Cargando…
Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of Glucose
Type 2 diabetes (T2D) is a major risk factor for heart failure. Diabetic cardiomyopathy (DC) is characterized by diastolic dysfunction and left ventricular hypertrophy. Epidemiological data suggest that hyperglycaemia contributes to the development of DC. Several cellular pathways have been implicat...
Autores principales: | Ducheix, Simon, Magré, Jocelyne, Cariou, Bertrand, Prieur, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215811/ https://www.ncbi.nlm.nih.gov/pubmed/30420836 http://dx.doi.org/10.3389/fendo.2018.00642 |
Ejemplares similares
-
O-GlcNAcylation and Metabolic Reprograming in Cancer
por: Jóźwiak, Paweł, et al.
Publicado: (2014) -
Editorial: O-GlcNAcylation: Expanding the Frontiers
por: Issad, Tarik, et al.
Publicado: (2019) -
O-GlcNAcylation Links ChREBP and FXR to Glucose-Sensing
por: Benhamed, Fadila, et al.
Publicado: (2015) -
O-GlcNAcylation: A New Cancer Hallmark?
por: Fardini, Yann, et al.
Publicado: (2013) -
The Role of O-GlcNAcylation in Immune Cell Activation
por: Qiang, Amy, et al.
Publicado: (2021)